-+ 0.00%
-+ 0.00%
-+ 0.00%
Hualan Biotech (002007.SZ) shares company dupliumab injection clinical trial application accepted
Share
Listen to the news

Zhitong Finance App News, Hualan Biotech (002007.SZ) issued an announcement. Recently, Hualan Ankang Biology Co., Ltd., the company's shareholding company, received a “Notice of Acceptance” issued by the State Drug Administration for the registration of a clinical trial application for dupriumab injections produced domestically. The drug is indicated for atopic dermatitis, asthma, prurigo nodular, chronic obstructive pulmonary disease, and bullous pemphigoid.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending